{"id":"W4414984131","doi":"10.1016/s2352-3026(25)00254-6","title":"Enasidenib plus venetoclax in patients with IDH2-mutated relapsed or refractory acute myeloid leukaemia or myelodysplastic syndrome (ENAVEN-AML): a multicentre, single-arm, phase 1b/2 trial","year":2025,"lang":"en","type":"article","venue":"The Lancet Haematology","topic":"Acute Myeloid Leukemia Research","field":"Medicine","cited_by":4,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; University of Toronto; Princess Margaret Cancer Centre; University Health Network","funders":"Celgene; AbbVie; Bristol-Myers Squibb","keywords":"Venetoclax; Myeloid leukaemia; Refractory (planetary science); Myelodysplastic syndromes; Myeloid leukemia; Myeloid; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":["metaepi_narrow"],"consensus_categories":[],"category_scores_codex":[0.000684594,0.0006275225,0.002650314,0.0006508374,0.0002211663,0.00005983642,0.0008402269,0.0005334605,0.0003787735],"category_scores_gemma":[0.00192325,0.0003598731,0.0001387243,0.001572534,0.0006348463,0.0002020168,0.0003379142,0.001743145,0.000211184],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.002554048,"about_ca_system_score_gemma":0.003468436,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001904009,"about_ca_topic_score_gemma":0.0004633315,"domain_scores_codex":[0.994902,0.0007711841,0.001122366,0.0009396502,0.0007232526,0.001541565],"domain_scores_gemma":[0.9955683,0.002001072,0.0004190333,0.001426525,0.000296988,0.0002880503],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9486426,0.004130279,0.004485963,0.0009542775,0.001550902,0.0254991,0.001581992,0.0001105452,0.0009988021,0.0002663467,0.009291973,0.002487182],"study_design_scores_gemma":[0.9418797,0.02217682,0.01251468,0.002286544,0.001690045,0.004632506,0.0005831652,0.004515659,0.001806134,0.0002236749,0.006665692,0.001025358],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9914822,0.0001845556,0.0001747487,0.002316971,0.0006454478,0.004236147,0.00008060192,0.0002504563,0.0006288561],"genre_scores_gemma":[0.9937637,0.0001270159,0.0007899299,0.001369925,0.0001805719,0.0004152316,0.0002688188,0.0001092586,0.002975567],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.0208666,"threshold_uncertainty_score":0.9998853,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.03281879553664856,"score_gpt":0.3313487312351916,"score_spread":0.298529935698543,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}